6127 Stock Overview
Joinn Laboratories(China)Co.,Ltd. provides preclinical and non-clinical services in the United States, the People’s Republic of China, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 4/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for 6127 from our risk checks.
Joinn Laboratories(China)Co.,Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥9.51 |
| 52 Week High | CN¥23.21 |
| 52 Week Low | CN¥8.10 |
| Beta | 0.52 |
| 1 Month Change | 7.22% |
| 3 Month Change | -2.96% |
| 1 Year Change | -57.12% |
| 3 Year Change | -81.23% |
| 5 Year Change | n/a |
| Change since IPO | -81.53% |
Recent News & Updates
Recent updates
Shareholder Returns
| 6127 | HK Life Sciences | HK Market | |
|---|---|---|---|
| 7D | 14.4% | -1.3% | 1.7% |
| 1Y | -57.1% | -62.9% | -7.1% |
Return vs Industry: 6127 exceeded the Hong Kong Life Sciences industry which returned -62.2% over the past year.
Return vs Market: 6127 underperformed the Hong Kong Market which returned -7.2% over the past year.
Price Volatility
| 6127 volatility | |
|---|---|
| 6127 Average Weekly Movement | 10.5% |
| Life Sciences Industry Average Movement | 12.2% |
| Market Average Movement | 7.4% |
| 10% most volatile stocks in HK Market | 15.0% |
| 10% least volatile stocks in HK Market | 3.6% |
Stable Share Price: 6127 has not had significant price volatility in the past 3 months.
Volatility Over Time: 6127's weekly volatility (11%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1995 | 2,510 | Dapeng Gao | www.joinn-lab.com |
Joinn Laboratories(China)Co.,Ltd. provides preclinical and non-clinical services in the United States, the People’s Republic of China, and internationally. It operates through three segments: Non-Clinical Studies Services; Clinical Trial and Related Services; and Sales of Research Models.
Joinn Laboratories(China)Co.,Ltd. Fundamentals Summary
| 6127 fundamental statistics | |
|---|---|
| Market cap | HK$13.39b |
| Earnings (TTM) | -HK$68.15m |
| Revenue (TTM) | HK$2.52b |
5.8x
P/S Ratio-213.5x
P/E RatioIs 6127 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 6127 income statement (TTM) | |
|---|---|
| Revenue | CN¥2.33b |
| Cost of Revenue | CN¥1.43b |
| Gross Profit | CN¥897.25m |
| Other Expenses | CN¥960.24m |
| Earnings | -CN¥62.99m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.084 |
| Gross Margin | 38.48% |
| Net Profit Margin | -2.70% |
| Debt/Equity Ratio | 0.3% |
How did 6127 perform over the long term?
See historical performance and comparison